Sang-Deep Acid-Chem Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-07-2024
- Paid Up Capital ₹ 0.49 M
as on 05-07-2024
- Company Age 31 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.50 Cr
as on 05-07-2024
- Revenue 31.20%
(FY 2022)
- Profit 81.44%
(FY 2022)
- Ebitda 266.87%
(FY 2022)
- Net Worth 26.88%
(FY 2022)
- Total Assets -20.44%
(FY 2022)
About Sang-Deep Acid-Chem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.49 M.
The company has closed loans amounting to ₹9.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Neel Shah and Krutarth Shah serve as directors at the Company.
- CIN/LLPIN
U24110MH1993PTC073488
- Company No.
073488
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Sang-Deep Acid-Chem Private Limited offer?
Sang-Deep Acid-Chem Private Limited offers a wide range of products and services, including Acetonitrile, Heptane, Solvent Ether, Methyl Tertiary Butyl Ether, Aromatic Hydrocarbon Solvent, Ortho Xylene, Carboxylate Esters, Ethyl Acetate, Alcohol Solvents, Normal Butanol.
Who are the key members and board of directors at Sang-Deep Acid-Chem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neel Shah  | Whole-Time Director | 07-Apr-2012 | Current |
| Krutarth Shah | Director | 18-Jun-2006 | Current |
Financial Performance of Sang-Deep Acid-Chem.
Sang-Deep Acid-Chem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 31.2% increase. The company also saw a substantial improvement in profitability, with a 81.44% increase in profit. The company's net worth Soared by an impressive increase of 26.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sang-Deep Acid-Chem?
In 2021, Sang-Deep Acid-Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jhs Chemi Pharma Private LimitedActive 20 years 4 monthsNeel Shah and Krutarth Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Central Bank Of India Creation Date: 04 Sep 2012 | ₹9.50 Cr | Satisfied |
How Many Employees Work at Sang-Deep Acid-Chem?
Sang-Deep Acid-Chem has a workforce of 5 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sang-Deep Acid-Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sang-Deep Acid-Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
